Trials / Completed
CompletedNCT00490945
Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of VEC-162 on Circadian Rhythm in Healthy Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety and efficacy of VEC-162 compared to matching placebo on circadian phase shift and sleep parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VEC-162 |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2005-03-01
- Completion
- 2005-03-01
- First posted
- 2007-06-25
- Last updated
- 2014-08-26
- Results posted
- 2014-08-26
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00490945. Inclusion in this directory is not an endorsement.